Dyslipoproteinemia in North America: The Lipid Research Clinics Program Prevalence Study.

30 The effects of changes in physical activity on major cardiovascular risk factors, hemodynamics, sympathetic function, and glucose utilization in man: a controlled study of four levels of activity Garry Jennings, Lisa Nelson, Paul Nestel, Murray Esler, Paul Korner, Deborah Burton, and Jeffrey Bazelmans 41 Cardiac Doppler flow velocities in human fetuses Kathryn L. Reed, Erik J. Meijboom, David J. Sahn, Sarah A. Scagnelli, Lilliam M. Valdes-Cruz, and Lewis Shenker

[1]  Johnson Dc,et al.  Pharmacology of the bipyridines: amrinone and milrinone. , 1986 .

[2]  J. Gwathmey,et al.  The effects of amrinone and related drugs on intracellular calcium in isolated mammalian cardiac and vascular smooth muscle. , 1986, Circulation.

[3]  J. Reeves,et al.  Effects of amrinone and milrinone on calcium influx into the myocardium. , 1986, Circulation.

[4]  I. Grupp,et al.  Myocardial actions of milrinone: characterization of its mechanism of action. , 1986, Circulation.

[5]  H. Lijnen,et al.  Analysis of coagulation and fibrinolysis during intravenous infusion of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction. , 1986, Circulation.

[6]  M. Marcus,et al.  Premortem assessment of myocardial area at risk with the use of intracoronary technetium macroaggregated albumin and gated nuclear imaging. , 1986, Circulation.

[7]  E. Sonnenblick,et al.  Effects of milrinone on left ventricular performance and myocardial contractility in patients with severe heart failure. , 1986, Circulation.

[8]  R. Lang,et al.  Milrinone versus dobutamine: contribution of altered myocardial mechanics and augmented inotropic state to improved left ventricular performance. , 1986, Circulation.

[9]  R. Myerburg,et al.  Effects of amrinone on contraction and K+-induced contracture of normal and subacutely failed cat ventricular muscle. , 1986, Circulation.

[10]  P. Reddy,et al.  Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043. , 1986, Circulation.

[11]  J. R. Blinks,et al.  Modification of myofibrillar responsiveness to Ca++ as an inotropic mechanism. , 1986, Circulation.

[12]  E. Sonnenblick,et al.  Milrinone for long-term therapy of severe heart failure: clinical experience with special reference to maximal exercise tolerance. , 1986, Circulation.

[13]  E. Braunwald,et al.  Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness. , 1986, Circulation.

[14]  H. Scholz,et al.  Phosphodiesterase-inhibiting properties of newer inotropic agents. , 1986, Circulation.

[15]  B. Pitt,et al.  Reduction of the size of infarction by allopurinol in the ischemic-reperfused canine heart. , 1986, Circulation.

[16]  B. Ransil,et al.  Effects of supine and lateral positions on cardiac output and intracardiac pressures: an experimental study. , 1986, Circulation.

[17]  J. Ross,et al.  Exercise-induced regional dysfunction with subcritical coronary stenosis. , 1986, Circulation.

[18]  C. Benedict,et al.  Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries. , 1986, Circulation.

[19]  J. Elion,et al.  Value and limitations of computer analysis of digital subtraction angiography in the assessment of coronary flow reserve. , 1986, Circulation.

[20]  H. Halperin,et al.  Determinants of blood flow to vital organs during cardiopulmonary resuscitation in dogs. , 1986, Circulation.

[21]  D. Kass,et al.  Determination of left ventricular end-systolic pressure-volume relationships by the conductance (volume) catheter technique. , 1986, Circulation.

[22]  D. Baim,et al.  Assessment of long-term therapy with milrinone and the effects of milrinone withdrawal. , 1986, Circulation.

[23]  P. Stern,et al.  Does amrinone inhibition of stimulated bone resorption involve Na+-Ca++ exchange? , 1986, Circulation.